Breast Cancer Research and Treatment

, Volume 134, Issue 3, pp 1247–1256

Cardiometabolic factors and breast cancer risk in U.S. black women

  • Jaclyn L. F. Bosco
  • Julie R. Palmer
  • Deborah A. Boggs
  • Elizabeth E. Hatch
  • Lynn Rosenberg


Previous studies have suggested that metabolic syndrome may be associated with an increased risk of breast cancer, particularly in postmenopausal women, but U.S. black women have not been assessed. We examined the associations of abdominal obesity, type 2 diabetes, hypertension, and high cholesterol individually and in combination with breast cancer incidence in the Black Women’s Health Study. By means of Cox regression models, we estimated incidence rate ratios (IRR) and 95 % confidence intervals (CI) for the associations of baseline and time-dependent values of self-reported abdominal obesity, type 2 diabetes, hypertension, and high cholesterol with breast cancer incidence. During 516,452 person years of follow-up (mean years = 10.5; standard deviation = 2.9) from 1995 to 2007, 1,228 breast cancer cases were identified. After adjustment for age, education, body mass index at age 18, physical activity, and individual cardiometabolic factors, neither individual nor combinations of cardiometabolic factors were associated with breast cancer incidence overall; the multivariable IRR was 1.04 (95 % CI 0.86–1.25) for the combination of ≥3 factors relative to the absence of all factors, and 1.17 (0.85–1.60) for having all four factors. Among postmenopausal women, however, the comparable IRRs were 1.23 (0.93–1.62) and 1.63 (1.12–2.37), respectively. Our findings provide some support for an association between cardiometabolic factors and breast cancer incidence among postmenopausal U.S. black women.


Metabolic syndrome Obesity Insulin resistance Breast cancer 



Atherosclerosis Risk in Communities


Body mass index


Black Women’s Health Study


Confidence interval


European Prospective Investigation of Cancer and Nutrition


High-density lipoprotein


Incidence rate ratio


MEtabolic syndrome and CANcer Study


Multivariable incidence rate ratio


Sex-hormone binding globulin


Women’s Health Initiative


  1. 1.
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRefGoogle Scholar
  2. 2.
    Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 287:356–359CrossRefGoogle Scholar
  3. 3.
    Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163:427–436PubMedCrossRefGoogle Scholar
  4. 4.
    Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2010) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case–control study. Nutr Metab Cardiovasc Dis 20:41–48PubMedCrossRefGoogle Scholar
  5. 5.
    Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML et al (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev 18:2046–2053CrossRefGoogle Scholar
  6. 6.
    Sinagra D, Amato C, Scarpilta AM, Brigandì M, Amato M, Saura G, Latteri MA, Caimi G (2002) Metabolic syndrome and breast cancer risk. Euro Rev Med Pharmacol Sci 6:55–59Google Scholar
  7. 7.
    Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M et al (2010) Metabolic syndrome and breast cancer in the Me-Can (MEtabolic syndrome and CANcer) project. Cancer Epidemiol Biomark Prev 19:1737–1745CrossRefGoogle Scholar
  8. 8.
    Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, Negri E, La Vecchia C (2011) Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol 22:2687–2692PubMedCrossRefGoogle Scholar
  9. 9.
    Porto L, Lora K, Soares J, Costa L (2011) Metabolic syndrome is an independent risk factor for breast cancer. Arch Gynecol Obstet 284:1271–1276PubMedCrossRefGoogle Scholar
  10. 10.
    Osaki Y, Taniguchi S-i, Tahara A, Okamoto M, Kishimoto T (2012) Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol 36:141–147PubMedCrossRefGoogle Scholar
  11. 11.
    Rose DP, Haffner SM, Baillargeon J (2007) Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocrine Rev 28:763–777CrossRefGoogle Scholar
  12. 12.
    Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE (1999) Waist circumference, waist: hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J Epidemiol 150:1316–1324PubMedCrossRefGoogle Scholar
  13. 13.
    Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’™ Health Study. Diabetes Care 26:1752–1758PubMedCrossRefGoogle Scholar
  14. 14.
    Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:823S–835SGoogle Scholar
  15. 15.
    Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRefGoogle Scholar
  16. 16.
    Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395–408PubMedCrossRefGoogle Scholar
  17. 17.
    Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H (2006) Hypertension, diuretics and breast cancer risk. J Hum Hypertens 20:727–732PubMedCrossRefGoogle Scholar
  18. 18.
    Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, La Vecchia C (1999) Hypertension and hormone-related neoplasms in women. Hypertension 34:320–325PubMedCrossRefGoogle Scholar
  19. 19.
    Furberg A-S, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160PubMedCrossRefGoogle Scholar
  20. 20.
    Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JMM (2009) New users of metformin are at low risk of incident cancer. Diabetes Care 32:1620–1625PubMedCrossRefGoogle Scholar
  21. 21.
    Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N (1998) Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomark Prev 7:483–488Google Scholar
  22. 22.
    Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson JE, Margolis KL, Muti P et al (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13:741–751PubMedCrossRefGoogle Scholar
  23. 23.
    Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2005) Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 165:2264–2271PubMedCrossRefGoogle Scholar
  24. 24.
    Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR (2008) HDL-cholesterol and incidence of breast cancer in the ARIC Cohort Study. Ann Epidemiol 18:671–677PubMedCrossRefGoogle Scholar
  25. 25.
    Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L (2007) A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomark Prev 16:1795–1802CrossRefGoogle Scholar
  26. 26.
    Palmer JR, Rao SR, Adams-Campbell LL, Rosenberg L (2001) Height and breast cancer risk: results from the Black Women’s Health Study (United States). Cancer Causes Control 12:343–348PubMedCrossRefGoogle Scholar
  27. 27.
    Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, Rosenberg L (2005) Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 16:346–354PubMedCrossRefGoogle Scholar
  28. 28.
    Krishan S, Rosenberg L, Djousse L, Cupple LA, Palmer JR (2007) Overall and central obesity and risk of type 2 diabetes. Obesity 15:1860–1866CrossRefGoogle Scholar
  29. 29.
    Cozier Y, Palmer JR, Horton NJ, Fredman L, Wise LA, Rosenberg L (2006) Racial discrimination and the incidence of hypertension in US black women. Ann Epidemiol 16:681–687PubMedCrossRefGoogle Scholar
  30. 30.
    Stephenson GD, Rose DP (2003) Breast cancer and obesity: an update. Nutr Cancer 45:1–6PubMedCrossRefGoogle Scholar
  31. 31.
    Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, van Leeuwen FE, on behalf of TFPAC (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18:137–157PubMedCrossRefGoogle Scholar
  32. 32.
    Band PR, Le ND, Fang R, Deschamps M (2002) Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 360:1044–1049PubMedCrossRefGoogle Scholar
  33. 33.
    Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149–156PubMedCrossRefGoogle Scholar
  34. 34.
    Kelsey JL (1993) Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15:256–263PubMedGoogle Scholar
  35. 35.
    Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47PubMedGoogle Scholar
  36. 36.
    Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7–16PubMedGoogle Scholar
  37. 37.
    Carter-Nolan PL, Adams-Campbell LL, Makambi K, Lewis S, Palmer JR, Rosenberg L (2006) Validation of physical activity instruments: Black Women’s Health Study. Ethn Dis 16:943–947PubMedGoogle Scholar
  38. 38.
    Cox DR (1972) Regression models and life-tables. J R Stat Soc B (Methodol) 34:187–220Google Scholar
  39. 39.
    Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New YorkGoogle Scholar
  40. 40.
    Rose DP, Komninou D, Stephenson G (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153–165PubMedCrossRefGoogle Scholar
  41. 41.
    Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins MZ et al (2009) Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125:2704–2710PubMedCrossRefGoogle Scholar
  42. 42.
    Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13:279–292PubMedCrossRefGoogle Scholar
  43. 43.
    Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence. Am J Epidemiol 156:349–352PubMedCrossRefGoogle Scholar
  44. 44.
    Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915–928PubMedCrossRefGoogle Scholar
  45. 45.
    Bruning PF (1987) Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability. J Steroid Biochem Mol Biol 27:487–492Google Scholar
  46. 46.
    Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510–1516PubMedCrossRefGoogle Scholar
  47. 47.
    Fast Stats: an interactive tool for access to SEER cancer statistics. Last accessed 21 Nov 2010
  48. 48.
    Kaaks R, Van Noord PAH, Den Tonkelaar I, Peeters PHM, Riboli E, Grobbee DE (1998) Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch “DOM” cohort. Int J Cancer 76:647–651PubMedCrossRefGoogle Scholar
  49. 49.
    Hall IJ, Newman B, Millikan RC, Moorman PG (2000) Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 151:754–764PubMedCrossRefGoogle Scholar
  50. 50.
    Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw K-T, Tehard B, Berrino F, Tjønneland A, Bigaard J, Olsen A et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762–771PubMedCrossRefGoogle Scholar
  51. 51.
    Adebamowo C, Ogundiran T, Adenipekun A, Oyesegun R, Campbell O, Akang E, Rotimi C, Olopade O (2003) Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res 5:R18–R24PubMedCrossRefGoogle Scholar
  52. 52.
    Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D’Agostino RB, Splansky GL, Anderson KM, Helsel WE (1990) Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst 82:286–290PubMedCrossRefGoogle Scholar
  53. 53.
    Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB (1990) Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131:794–803PubMedGoogle Scholar
  54. 54.
    Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, Shore RE (1999) Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol 28:1026–1031PubMedCrossRefGoogle Scholar
  55. 55.
    Lipscombe LL, Goodwin PJ, Zinman B, mclaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98:349–356PubMedCrossRefGoogle Scholar
  56. 56.
    Weiderpass E, Gridley G, Persson I, Nyrén O, Ekbom A, Adami H-O (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71:360–363PubMedCrossRefGoogle Scholar
  57. 57.
    Baron J, Weiderpass E, Newcomb P, Stampfer M, Titus-Ernstoff L, Egan K, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12:875–880PubMedCrossRefGoogle Scholar
  58. 58.
    Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699–1703PubMedCrossRefGoogle Scholar
  59. 59.
    Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26:781–785PubMedCrossRefGoogle Scholar
  60. 60.
    Sellers T, Sprafka J, Gapstur S, Rich S, Potter J, Ross J, McGovern P, Nelson C, Folsom A (1994) Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology 5:102–108PubMedCrossRefGoogle Scholar
  61. 61.
    Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Gale EA et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92:2070–2075PubMedCrossRefGoogle Scholar
  62. 62.
    Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S, for the Japan Public Health Center-Based Prospective Study Group (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877Google Scholar
  63. 63.
    Lindgren A, Pukkala E, Tuomilehto J, Nissinen A (2007) Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer 121:641–644PubMedCrossRefGoogle Scholar
  64. 64.
    Furberg A-S, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, Ellison PT, Thune I (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomark Prev 14:33–40Google Scholar
  65. 65.
    Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466–473PubMedCrossRefGoogle Scholar
  66. 66.
    Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66:33–38PubMedCrossRefGoogle Scholar
  67. 67.
    White KK, Park S-Y, Kolonel LN, Henderson BE, Wilkens LR (2012) Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer. doi:10.1002/ijc.27373
  68. 68.
    Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML (2008) Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic white women living in US Southwestern States. Am J Epidemiol 167:447–456PubMedCrossRefGoogle Scholar
  69. 69.
    Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304–1308PubMedCrossRefGoogle Scholar
  70. 70.
    Jonasson JM, Ljung R, Talbäck M, Haglund B, Gudbjörnsdòttir S, Steineck G (2009) Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden. Diabetologia 52:1745–1754PubMedCrossRefGoogle Scholar
  71. 71.
    Bosco JLF, Antonsen S, Sørensen HT, Pedersen L, Lash TL (2011) Metformin and incident breast cancer among diabetic women: a population-based case–control study in Denmark. Cancer Epidemiol Biomark Prev 20:101–111CrossRefGoogle Scholar
  72. 72.
    Moysich KB, Beehler GP, Zirpoli G, Choi J-Y, Baker JA (2008) Use of common medications and breast cancer risk. Cancer Epidemiol Biomark Prev 17:1564–1595CrossRefGoogle Scholar
  73. 73.
    Rose DP, Royak-Schaler R (2001) Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev 25:16–31PubMedGoogle Scholar
  74. 74.
    Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR (2001) Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc 93:267–275PubMedGoogle Scholar
  75. 75.
    Cozier Y, Palmer JR, Rosenberg L, Adams-Campbell LL (2001) Recent mammography use among African-American women. Ethn Dis 11:188–191PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2012

Authors and Affiliations

  • Jaclyn L. F. Bosco
    • 1
    • 2
  • Julie R. Palmer
    • 3
  • Deborah A. Boggs
    • 3
  • Elizabeth E. Hatch
    • 4
  • Lynn Rosenberg
    • 3
  1. 1.Dana-Farber Cancer InstituteBostonUSA
  2. 2.Section of Geriatrics, Department of MedicineBoston University School of MedicineBostonUSA
  3. 3.Slone Epidemiology Center at Boston UniversityBostonUSA
  4. 4.Department of EpidemiologyBoston University School of Public HealthBostonUSA

Personalised recommendations